【摘要】 作者应用荧光分光光度法测定了５０名健康人（对照组），１４例肝硬化和３０例肝癌患者的血清硒含量。对照组为０．７７９±０．１１６μｍｏｌ／Ｌ，肝硬化组为０．６８３±０．１３９μｍｏ／Ｌ，肝场组为０．６４６±０．２０８μｍｏｌ／Ｌ。测定结果与健康人组相比呈显著性（肝硬化组）和极显著性（肝癌组）差异，Ｐ值分别＜０．０５和＜０．０１，提示血清硒含量是肝病，特别是肝癌诊断的一项指标。更多还原

【Abstract】 erumiselenium Se was measured in pa-tients with primary liver cancer (PCL, n= 30,0. 646±0. 208μmol/L) , liver cirrhosis (LC, n= 14, 0. 683±0. 139μmol/L) Serumiselenium(Se) was measured in patients with primaryliver cancer (PLC, n=30, 0. 646 ±0.208μmol/L) , liver cirrhosis (LC, n = 14, 0.683 ± 0. 139μmol/L) and normal subjects(NS ,n= 50, 0. 779±0. 116 μmol/L). Signifi-cant difference were showed between PLC,LC patients and normal subjects (P<0. 001 ,P< 0. 05, respectively). The data suggestedthat the measurement of serum Se may beused as an indicator of diagnosis for PLC andLC.更多还原